Review
Aug 2026
Weissella as an emerging probiotic candidate for IBD: current evidence, challenges, and future perspectives”
This review consolidates current insights on Weissella SP, an emerging and underexplored genus of Lactic acid bacteria with unique metabolic and immunomodulatory properties, positioning Weissella as an underexplored yet promising component of next-generation probiotic blends for IBD therapeutics.
Hima Sebastian, B. Babu, K. Gayathri et al.
· Antonie van Leeuwenhoek · 0 citations